Bioequivalence Studies of New Generic Formulations of Vildagliptin and Fixed-Drug Combination of Vildagliptin and Metformin Versus Respective Originator Products in Healthy Volunteers

INTRODUCTION: Vildagliptin and metformin are two well-established oral antidiabetics with a complementary mechanism of action. Two new generic products, vildagliptin and its fixed-drug combination (FDC) with metformin, were tested for bioequivalence versus the approved originator reference products...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnaars, Yvonne, Gaikwad, Sumedh, Gottwald-Hostalek, Ulrike, Klingberg, Ulrike, Vadla, Hari Kiran Chary, Prathap, Vamshi Ramana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174400/
https://www.ncbi.nlm.nih.gov/pubmed/35543870
http://dx.doi.org/10.1007/s13300-022-01269-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174400/
https://www.ncbi.nlm.nih.gov/pubmed/35543870
http://dx.doi.org/10.1007/s13300-022-01269-1

Ejemplares similares